In case of glioma or breast cancers, the GDNF-Ret signaling pathway can be blocked by GAS1 (growth arrest-specific 1) or by some Ret kinase inhibitors leading to the impairment of tumor growth [97,98]. Here, GAS1 is linked to neoplasm.